Infinity Pharmaceuticals, Inc. (INFI): Price and Financial Metrics
Infinity Pharmaceuticals, Inc. (INFI)
Today's Latest Price: $0.81 USD
0.05 (6.20%)
Updated Apr 3 12:00am
Add INFI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
INFI Stock Summary
- With a price/sales ratio of 16.39, Infinity Pharmaceuticals Inc has a higher such ratio than 94.15% of stocks in our set.
- Over the past twelve months, INFI has reported earnings growth of 299.18%, putting it ahead of 95.71% of US stocks in our set.
- As for revenue growth, note that INFI's revenue has grown -86.23% over the past 12 months; that beats the revenue growth of merely 1.11% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Infinity Pharmaceuticals Inc, a group of peers worth examining would be MTEM, APVO, MNDO, ICCC, and KPTI.
- Visit INFI's SEC page to see the company's official filings. To visit the company's web site, go to www.infi.com.
INFI Daily Price Range
INFI 52-Week Price Range
INFI Stock Price Chart More Charts
INFI Price/Volume Stats
| Current price | $0.81 | 52-week high | $1.87 |
| Prev. close | $0.77 | 52-week low | $0.60 |
| Day low | $0.78 | Volume | 139,500 |
| Day high | $0.86 | Avg. volume | 208,966 |
| 50-day MA | $1.12 | Dividend yield | N/A |
| 200-day MA | $1.22 | Market Cap | 46.70M |
Infinity Pharmaceuticals, Inc. (INFI) Company Bio
Infinity Pharmaceuticals, Inc. discovers, develops, and delivers medicines to patients with difficult-to-treat diseases. Its lead product candidate includes IPI-145, an oral inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) for the treatment of hematologic malignancies. The company was founded in 2001 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...